Status:
RECRUITING
Binaural Sound for Remimazolam Maintenance
Lead Sponsor:
Gangnam Severance Hospital
Conditions:
General Anesthesia
Prostate Cancer Stage
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
It is important to decrease the remifentanil dose for general anesthesia maintenance when using remimazolam. We will evaluate the effect of binaural sound on general anesthesia maintenance with remima...
Eligibility Criteria
Inclusion
- Patients scheduled for general anesthesia
- Patients aged 20-60
- Patients with American Society of Anesthesiologist physical status classification 1-2
- Patients with ideal body weight 50-80 kg
Exclusion
- Patients with hearing disability
- Patients using opioids or sedatives in 1 week
- Patients who are dependent for alcoholics or drugs
- Patients with hypersensitivities to remimazolam or remifentanil
- Patients with arrhythmia, cardiovascular disease, heart failure, or hypovolemia
- Patients with liver failure
Key Trial Info
Start Date :
July 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2025
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06497283
Start Date
July 12 2024
End Date
February 28 2025
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gangnam Severance Hospital
Seoul, South Korea